EDITORIAL: FDA rules will shutter many vape shops, including in Las Vegas

For decades, the federal government, health care advocates and doctors have warned of the hazards of smoking cigarettes, and rightly so. Yet just as more and more smokers are finding a way to kick carcinogen-laden cancer sticks, D.C. bureaucrats are coming to the rescue of the tobacco industry by over-regulating e-cigarettes.As Caroline Kitchens reported last week for RealClear Health, unless something changes soon, the doomsday clock will strike midnight on the e-cigarette industry.

New drug offers hope for patients with bladder cancer

A bladder cancer drug discovered and developed at The University of Kansas Cancer Center is set to become its first cancer drug to go from bench to bedside. KU Cancer Center’s nationally recognized proof-of-concept center and product development arm, the Institute for Advancing Medical Innovation , translates laboratory and bedside discoveries into new drugs, diagnostic tests and medical devices with the goal of advancing promising medical innovations to patients.

George Whitaker III: Finding new hope against throat cancer

Since 2010, when his throat cancer was first diagnosed, George Whitaker III has had more than 60 radiation treatments, enough to change his morning routine for good. Since 2010, when his throat cancer was first diagnosed, George Whitaker III has had more than 60 radiation treatments, enough to change his morning routine for good.

NHC Announces Common Dividend

)– National HealthCare Corporation (NYSE MKT: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 45 cents per common share to shareholders of record on March 31, 2017 and …

Bad behavior all around

… repeal or block masses of regulations, and then defeated Democratic amendments to keep those that protect children’s health from air pollution and lead in water, safety of miners, nuclear power plant safety, insurance coverage for persons with …

Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify …

Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a privately held biotech company based in Madison, Wisconsin and Cambridge, Massachusetts, today announced that they have entered into a collaboration to identify novel biomarkers of Angelman syndrome by analyzing metabolomic profile data as part of Ovid’s ongoing randomized, double-blind, placebo-controlled Phase 2 clinical trial .

Sanders-Cruz debate is a ratings hit, but their views aren’t winning the Hill

Sen. Bernie Sanders , left, and Sen. Ted Cruz CNN scored a surprise hit last night with a broadcast from a parallel universe – a debate about “the future of Obamacare,” starring presidential primary season runners-up Sens. Bernie Sanders and Ted Cruz . According to AdWeek, the nearly two-hour special attracted 2.46 million viewers, and 932,000 from the coveted demographic of viewers ages 25 to 54. Those were the kind of numbers enjoyed by Fox News, which typically laps CNN for viewers – and they came not for a tabloid special but for a debate about health insurance.

Connector, Baker hoping for enough a oerunwaya to adjust to ACA changes

The governor said Monday that based on his conversations with “a number of folks in D.C.” there does not appear to be consensus around what STATE HOUSE, BOSTON, FEB. 7, 2017..Acknowledging that the health care landscape could be drastically different a year from now, Gov. Charlie Baker on Monday said that the federal government needs to give states enough time to adapt to changes to the Affordable Care Act.

Cruz, Sanders face off on Obamacare

Ted Cruz and Bernie Sanders — two senators with diametrically opposed views of government’s role in health care — are facing off at a CNN town hall debate over the future of Obamacare. The event, moderated by CNN’s Jake Tapper and Dana Bash, is certain to highlight the many challenges surrounding efforts to dismantle the Affordable Care Act — a sweeping health care law that covers some 20 million Americans.

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published

Diffusion Pharmaceuticals Inc. , a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer and other hypoxia-related diseases, today announced that the data from the Phase 1/2 clinical trial evaluating the safety and efficacy of trans sodium crocetinate in newly diagnosed glioblastoma multiforme has been published in the print edition of the peer-reviewed Journal of Neurosurgery . Results from the Phase 1/2 clinical trial in 59 patients showed that 36.3% of the full TSC dose patients were alive at two years, compared to historical two-year survival rates ranging from 27% to 30%.

BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2…

BioRestorative Therapies, Inc. , a life sciences company focused on stem cell-based therapies, today announced that it has received clearance by the U.S. Food and Drug Administration to commence a Phase 2 clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. The Phase 2 clinical trial is a 72 patient, randomized, double-blind, controlled, multi-center study designed to evaluate safety and efficacy of a single dose of BRTX-100 in treating chronic lower lumbar disc disease.

Haven’t Gotten Your W-2? Take These Steps

You’re ready to file your taxes – except for one thing: You’re still awaiting an IRS Form W-2 from an employer. Each January, companies issue W-2s to inform workers, and Uncle Sam, of the amount of money the worker made during the previous year and how much in income, Social Security and Medicare taxes was withheld.

Study: GOP Medicaid plan could save more than $100 billion

Transforming Medicaid into a block grant or per capita cap program could save the federal government more than $100 billion over five years, a new study found. The research from the healthcare firm Avalere Health was released as the GOP-controlled Congress eyes overhauling Medicaid as part of a replacement to Obamacare.

Facts About Social Security, Medicare in the Age of Trump May Surprise You

While the era of “alternative facts” dawned in Washington, experts from across the ideological spectrum gathered in the capital for a review of real facts about our two most important retirement programs: Social Security and Medicare. The annual policy research conference of the National Academy of Social Insurance focused on the group’s new report to the Donald Trump administration and Congress on the future of all our social insurance programs – those that cover retirement, but also those that protect the disabled, jobless, impoverished poverty and frail.

Dental benefits manager selected

… the companies indicates the payments are expected to total about $300 million over two years. Dentists and other oral health care providers would be reimbursed for services by the companies instead of the Medicaid program, as they are now. Adults …

Important Investor Alert: Lundin Law PC Announces Securities Class…

Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Regulus Therapeutics Inc. . Investors who purchased or otherwise acquired Regulus shares between January 21, 2016 and June 27, 2016 inclusive , are encouraged to contact the firm in advance of the To participate in this class action lawsuit, click here .

Women could take big hit if ACA is tossed

From a return to higher premiums based on gender, to gaps in coverage for birth control and breast pumps, experts say women could end up paying more for less if the Obama-era health care law is repealed. The 2010 law ended a common industry practice of charging women more than men for policies purchased directly from an insurer.